• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

ZFAND5 Polyklonaler Antikörper

ZFAND5 Polyklonal Antikörper für WB, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 25048-1-PBS

Synonyme

AN1-type zinc finger protein 5, ZFAND5A, Zinc finger A20 domain-containing protein 2, ZNF216

Filter:
  • Western Blot (WB) analysis of various lysates using ZFAND5 Polyclonal antibody (25048-1-AP)

    WB analysis using 25048-1-AP (same clone as 25048-1-PBS)

    Various lysates were subjected to SDS PAGE followed by western blot with 25048-1-AP (ZFAND5 antibody) at dilution of 1:800 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 25048-1-PBS in a different storage buffer formulation.

Geprüfte Anwendungen

Produktinformation

25048-1-PBS bindet in WB, Indirect ELISA ZFAND5 und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen ZFAND5 fusion protein Ag19311
Vollständiger Name zinc finger, AN1-type domain 5
Berechnetes Molekulargewicht 213 aa, 23 kDa
Beobachtetes Molekulargewicht 23-35 kDa
GenBank-ZugangsnummerBC027707
Gene symbol ZFAND5
Gene ID (NCBI) 7763
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

ZFAND5 is Involved in protein degradation via the ubiquitin-proteasome system and may act by anchoring ubiquitinated proteins to the proteasome. It plays a role in ubiquitin-mediated protein degradation during muscle atrophy and in the regulation of NF-kappa-B activation and apoptosis. It can inhibit NF-kappa-B activation triggered by overexpression of RIPK1 and TRAF6 but not of RELA. It also inhibits tumor necrosis factor (TNF), IL-1, and TLR4-induced NF-kappa-B activation in a dose-dependent manner.